Cardiovascular Intervention and Therapeutics

Cardiovascular Intervention and Therapeutics is the official journal of the Japanese Association of Cardiovascular Intervention and Therapeutics, created in 2009 when two Japanese societies merged, and is published by Springer with a 2025 Journal Impact Factor of 5.5.《心血管介入与治疗》（Cardiovascular Intervention and Therapeutics）是日本心血管介入与治疗学会的官方期刊，2009 年由两家日本学会的刊物合并而成，由（Springer）出版，2025 年影响因子为 5.5。

Scope

• The journal spans the field of cardiovascular disease, with coverage of cardiac and peripheral interventions and therapeutics.本刊覆盖心血管疾病的各个领域，包括心脏与外周的介入与治疗。
• Coronary intervention, including stent design, imaging guidance and physiological assessment, is its largest area.冠状动脉介入，包括支架设计、影像引导与生理学评估，是其最大的领域。
• Non-coronary and structural intervention, including transcatheter valve therapy and closure devices, is covered.非冠状动脉与结构性心脏病介入，包括经导管瓣膜治疗与封堵器械，均有收录。
• Peripheral vascular intervention and catheter-based treatment of aortic and peripheral disease are published.外周血管介入以及主动脉与外周疾病的导管治疗均予发表。
• Intravascular imaging and functional assessment of coronary lesions are treated as core clinical topics.血管内影像与冠状动脉病变的功能学评估，被视为核心临床议题。
• Registry studies and clinical outcome research are within scope, reflecting the society's Japanese database.注册登记研究与临床结局研究均在其范围之内，反映出学会的日本数据库基础。
• Images in cardiovascular intervention and invited review articles are regular features of each issue.介入影像与约稿综述，是每期的固定栏目。

History

• The journal appeared in 2009, when the Japanese Society of Interventional Cardiology and the Japanese Association of Cardiovascular Catheterization and Therapeutics merged to form JACVIT.本刊于 2009 年问世，其时日本介入心脏病学会与日本心血管导管治疗学会合并为（JACVIT）。
• The two journals published by the predecessor societies were merged at the same time into a single English-language journal, which began with volume 25.两家前身学会各自的刊物同时合并为一份英文期刊，并自第 25 卷起出版。
• Its volume numbering therefore reaches back to 1987, the first year of the predecessor publication.因此其卷次可追溯至 1987 年，即前身刊物创办之年。
• It is published on behalf of the society by Springer, with four issues a year.本刊代表学会由（Springer）出版，每年四期。
• Its impact factor stood at 3.1 in 2023 and 5.5 in 2025.其影响因子在 2023 年为 3.1，2025 年为 5.5。
• The journal is indexed in the Emerging Sources Citation Index and Scopus.本刊被新兴来源引文索引与（Scopus）收录。

Editors

• Kenichi Sakakura leads the journal as editor-in-chief, according to the publisher's journal page.据出版方期刊页，Kenichi Sakakura 担任本刊主编。
• The associate editors are based at Chiba University, Kansai Medical University, Toho University, Keio University, Yokohama City University and Tokyo Medical University.副主编分别来自千叶大学、关西医科大学、东邦大学、庆应大学、横滨市立大学与东京医科大学。
• Manuscripts are peer reviewed, and the journal publishes original articles, intervention images and invited reviews.稿件经同行评审，本刊发表原创论文、介入影像与约稿综述。
• The journal uses a hybrid publishing model, so authors may publish open access on payment of a charge.本刊采用混合出版模式，作者可付费选择开放获取发表。
• The editorial team is closely tied to the society's annual scientific meeting and its training programmes.编辑团队与学会的年度学术会议及其培训项目关系密切。
• Submissions are handled through the publisher's online editorial system, with a median time to first decision of four days reported for 2025.投稿经出版方的在线编辑系统处理，2025 年公布的首次决定中位时间为四天。